19-11106668-T-A
Variant summary
Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PS4PM5_StrongPP1_StrongPM2PP4PS3_Moderate
This summary comes from the ClinGen Evidence Repository: The NM_000527.5(LDLR):c.798T>A (p.Asp266Glu) variant is classified as Pathogenic for Familial Hypercholesterolemia by applying evidence codes (PS4, PP1_Strong, PM5_Strong, PM2, PS3_Moderate and PP4) as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (https://doi.org/10.1101/2021.03.17.21252755). The supporting evidence is as follows: PS4 - Variant meets PM2. Identified in over 10 unrelated index cases from Center of molecular biology and gene therapy with FH diagnosis.PP1_strong - variant segregates with phenotype in over 30 informative meiosis in several families from different laboratories.PM5_strong - Four more missense variants described in same codon: --- 3 variants classified as Pathogenic, so PM5_Strong is met.PM2 - PopMax MAF = 0.00007740 (0.008%) in european non-finnish exomes (gnomAD v2.1.1).PS3_moderate - Level 2 assay: PMID 1301956: Hmz patients' fibroblasts, 125I-LDL assays - results - 15-30% LDLR activity (but all cycle was tested) ---- Overall LDLR activity is below 70% of wild-type activity, so PS3_moderate is Met.PP4 - Variant meets PM2. Identified in over 10 unrelated index cases from Center of molecular biology and gene therapy with FH diagnosis. LINK:https://erepo.genome.network/evrepo/ui/classification/CA023765/MONDO:0007750/013
Frequency
Consequence
NM_000527.5 missense
Scores
Clinical Significance
Conservation
Publications
- hypercholesterolemia, familial, 1Inheritance: AD, SD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen
- homozygous familial hypercholesterolemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 17 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000527.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LDLR | MANE Select | c.798T>A | p.Asp266Glu | missense | Exon 5 of 18 | NP_000518.1 | P01130-1 | ||
| LDLR | c.798T>A | p.Asp266Glu | missense | Exon 5 of 18 | NP_001182727.1 | P01130-5 | |||
| LDLR | c.675T>A | p.Asp225Glu | missense | Exon 4 of 17 | NP_001182728.1 | P01130-4 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LDLR | TSL:1 MANE Select | c.798T>A | p.Asp266Glu | missense | Exon 5 of 18 | ENSP00000454071.1 | P01130-1 | ||
| LDLR | TSL:1 | c.1056T>A | p.Asp352Glu | missense | Exon 5 of 18 | ENSP00000252444.6 | J3KMZ9 | ||
| LDLR | TSL:1 | c.798T>A | p.Asp266Glu | missense | Exon 5 of 18 | ENSP00000453346.1 | P01130-5 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152226Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000318 AC: 8AN: 251482 AF XY: 0.0000294 show subpopulations
GnomAD4 exome AF: 0.0000315 AC: 46AN: 1461876Hom.: 0 Cov.: 31 AF XY: 0.0000399 AC XY: 29AN XY: 727238 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152226Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74368 show subpopulations
Age Distribution
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at